



















and Data Analysis Workflow for Sequencing and Identification of Intact Glycopeptides ” written by Sz‐Wei Wu
Figure S1





























um er o a   ax mum 
0  1344.39502 2.33 12.79 
1  1344.59563 7.96 43.67 
2  1344.79620 14.40 79.00 
3  1344.99673 18.23 100.00 
4  1345.19724 18.05 99.01 
5  1345.39773 14.83 81.38 
6  1345.59821 10.50 57.62 
7  1345.79867 6.57 36.03 
8 1345 99913 3 69 20 26  . .  .  
9  1346.19959 1.89 10.38 
10  1346.40003 0.89 4.90 
11  1346.60048 0.39 2.15 
12  1346.80093 0.16 0.88 
13  1347.00138 0.06 0.34 
14  1347.20183 0.02 0.12 
15  1347.40232 0.01 0.04 
16  1347.60283 0.00 0.01 
17 1347.80333 0.00 0.00    























Erik_sEGFR_HCDpdETDCID_130912194806 #8766 RT: 39.61 AV: 1 NL: 5.36E3















































Erik sEGFR HCDpdETDCID 130912194806 #8752 RT: 39.55 AV: 1 NL: 1.00E8
Figure S6
_ _ _



































































0 1385 20770 2 10 11 66  .  .  .  
1  1385.40831 7.36 40.91 
2  1385.60888 13.66 75.93 
3  1385.80942 17.74 98.56 
4  1386.00993 18.00 100.00 
5  1386.21043 15.15 84.20 
6  1386.41091 10.99 61.05 
7  1386.61138 7.03 39.08 
8  1386.81184 4.05 22.49 
9  1387.01230 2.12 11.80 
10  1387.21275 1.03 5.70 
11  1387.41321 0.46 2.55 
12  1387.61365 0.19 1.07 
13  1387.81411 0.08 0.42 
14 1388 01457 0 03 0 15  .  .  .  
15  1388.21505 0.01 0.05 
16  1388.41557 0.00 0.02 
17  1388.61617 0.00 0.00 




















Erik_sEGFR_HCDpdETDCID_130912194806 #8788 RT: 39.69 AV: 1 NL: 1.69E8







































950 1000 1050 1100 1150 1200 1250 1300 1350 1400 1450 1500 1550 1600
m/z
0
1175.8490 1559.20561009.9807926.4100 1247.7662 1415.59271353.8060 1469.8315
MS survey from which m/z 1320 was selected for MS/MS
Calculated* isotope distribution for the









0  1320.38657 2.46 13.33 
1  1320.58718 8.30 44.88 
   
2  1320.78774 14.80 80.08 
3  1320.98827 18.49 100.00 
4  1321.18878 18.06 97.69 
5  1321.38927 14.65 79.23 
6 1321 58974 10 23 55 36  .  .  .  
7  1321.79021 6.32 34.16 
8  1321.99066 3.50 18.96 
9  1322.19111 1.77 9.59 
10  1322.39156 0.83 4.47 
11  1322.59200 0.36 1.93 
12  1322.79245 0.14 0.78 
13  1322.99290 0.05 0.29 
14  1323.19335 0.02 0.10 
15  1323.39384 0.01 0.03 
16  1323.59436 0.00 0.01 
17  1323.79500 0.00 0.00 





“Novel LC MS2 Product Dependent Parallel Data Acquisition Function
Figure S11






Erik_sEGFR_HCDpdETDCID_130912194806 #8641 RT: 39.12 AV: 1 NL: 2.68E5












































Erik_sEGFR_HCDpdETDCID_130912194806 #8632 RT: 39.07 AV: 1 NL: 1.53E8




Erik_sEGFR_HCDpdETDCID_130912194806 #8632 RT: 39.07 AV: 1 NL: 5.89E5






















































































0  1293.84820 5.40 25.88 
1 1294 09896 14 54 69 65
   
  . .  .  
2  1294.34966 20.80 99.65 
3  1294.60033 20.87 100.00 
4  1294.85097 16.41 78.62 
5  1295.10159 10.72 51.38 
6  1295.35220 6.04 28.96 
7  1295.60280 3.01 14.42 
8  1295.85340 1.35 6.46 
9  1296.10398 0.55 2.64 
10 1296 35457 0 21 0 99  . .  .  
11  1296.60515 0.07 0.35 
12  1296.85575 0.02 0.11 
13  1297.10637 0.01 0.03 
14  1297.35702 0.00 0.01 
15  1297.60764 0.00 0.00 






Erik_sEGFR_HCDpdETDCID_130912194806 #8640 RT: 39.12 AV: 1 NL: 3.13E5
T FTMS + NSI d F ll 2 1294 10@h d35 00 [120 00 2000 00]
415TDLHAFENLEIIR427 The fragments clearly indicate the presence of both peptides






































































Erik_sEGFR_HCDpdETDCID_130912194806 #8550 RT: 38.74 AV: 1 NL: 6.31E3
















































1613.98281365.2177657.2125 1883.3279990.8770 1495.6156512.1762 822.6029
Heterodimer of  &  AND homodimer of 
MS survey from which the m/z 1383 ion was selected for MS/MS; precursor ion in the insert
Figure S17
Erik_sEGFR_HCDpdETDCID_130912194806 #8544 RT: 38.71 AV: 1 NL: 5.87E7
T: FTMS + p NSI Full ms [300.00-2000.00]
90
100
1153.1744 Erik_sEGFR_HCDpdETDCID_130912194806 #8544 RT: 38.71 AV: 1 NL: 6.30E5














































































1359.10171275.2137 1392.41161079.1517 1314.0605 1431.64381029.4996
Calculated* isotope distribution for the Man7









0  1383.20355 2.14 11.90 
1 1383 40416 7 46 41 48
 
  . .  .  
2  1383.60473 13.78 76.59 
3  1383.80527 17.80 98.96 
4  1384.00578 17.99 100.00 
5  1384.20627 15.09 83.89 
6  1384.40675 10.91 60.63 
7  1384.60723 6.96 38.70 
8  1384.80769 4.00 22.21 
9  1385.00815 2.09 11.62 
10 1385.20860 1.01 5.60    
11  1385.40905 0.45 2.51 
12  1385.60949 0.19 1.05 
13  1385.80995 0.07 0.41 
14  1386.01041 0.03 0.15 
15 1386 21088 0 01 0 05  . .  .  
16  1386.41141 0.00 0.01 
17  1386.61195 0.00 0.00 





Erik_sEGFR_HCDpdETDCID_130912194806 #8529 RT: 38.65 AV: 1 NL: 6.19E3










































 3+  2+
Man9
400 600 800 1000 1200 1400 1600 1800 2000
m/z
0
10 1651.1980 1891.38791261.6912 1500.5360991.2095657.1502 836.3849528.0954
MS survey from which the m/z 4448 ion was selected for MS/MS; precursor ion in the insert
Figure S20
Erik_sEGFR_HCDpdETDCID_130912194806 #8520 RT: 38.60 AV: 1 NL: 3.95E7




Erik_sEGFR_HCDpdETDCID_130912194806 #8520 RT: 38.60 AV: 1 NL: 2.04E5














































































919.1252 1275.54791102.1984 1473.6359982.4657 1359.1042 1416.61941050.4728 1541.3280
Calculated* isotope distribution for the Man8









0  1448.02468 1.82 10.23 
1 1448 22530 6 61 37 09
 
  .  .  .  
2  1448.42587 12.69 71.15 
3  1448.62641 17.01 95.41 
4  1448.82693 17.83 100.00 
5  1449.02743 15.50 86.96 
6  1449.22792 11.61 65.12 
7  1449.42840 7.68 43.05 
8  1449.62887 4.56 25.59 
9  1449.82933 2.47 13.86 
10 1450 02979 1 23 6 92  .  .  .  
11  1450.23024 0.57 3.20 
12  1450.43070 0.25 1.39 
13  1450.63115 0.10 0.56 
14  1450.83161 0.04 0.21 
15  1451.03209 0.01 0.08 
16  1451.23261 0.00 0.02 
17  1451.43312 0.00 0.01 
18  1451.63379 0.00 0.00  
 
*the peptide is oxidized in these glycoforms
